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Personal examination of 39 cases of Fabry's disease, with special respect to a chronogenetical 
analysis, revealed interesting temporal features both in the age of onset and the age of death. 
Reviewing the literature on Fabry's disease, we found the description of 470 cases. Of 
these we personally examined 39 (Franceschetti 1973). Although the purpose of our study 
was not a chronogenetical analysis, we obtained some interesting temporal features. 
The genetical analysis of our material produced a series of evidences on the sex-linked 
genetical transmission of Fabry's disease, namely: 
1. The ratio, affected males/affected females, is compatible with the theoretical ra-
tio 1 : 2. 
2. In 120 cases the gene was transmitted from mother to son. 
3. Transmission from father to son was never firmly proved. 
4. Sons of hemizygotes are normal. 
5. Heterozygotes inherit their gene more frequently from the mother than from the 
father (ratio compatible with the theoretical ratio 1: 3). 
6. If one of the parents marries twice, children of both marriages follow the expected 
pattern. 
7. Linkage data support a sex-linked inheritance. 
8. Chromosomal examinations are normal. 
AGE OF ONSET 
The cornea verticillata and the angiokeratomes are the two most constant features of 
Fabry's disease. But patients become aware of their ophthalmological lesions only late in the 
disease, when hypertensive lesions also appear. 
We tabulated the age at which cutaneous lesions were first noted and, despite the biases 
of these data, we fit a gaussian curve (Fig. 1). To do this, we disregarded patients with onset 
before 7. In fact, the high number of onsets reported at the age of 6 is, in our opinion, due 
only to the fact that the lesions were detected when the subjects went to school. We also had 
to exclude the cases with late onset. The mean age is 13.982. Only 3 cases reported showed 
no cutaneous lesions (Jensen 1966, Kemp 1967, and Nakao et al. 1967). 
A close analysis of the genealogical trees reveals the following chronogenetical facts: 
1. In some families the age of onset is approximatively the same for each member; e.g.: 
family I of Christensen Lou et al. (1970), where case IV/10 had his first symptoms at age 10 
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Fig. 1. Age of onset of Fabry's disease. 
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Fig. 2. Fabry's disease. [Family I of Christensen Lou et al. 1970]. 
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Fig. 3. Fabry's disease. [Iowa kindred of von Gemmingen et al. 1965]. 
and IV/11 at age 12; and for two step brothers examined by A. Denden and myself onset 
was at 16 (Denden and Franceschetti 1968). 
2. In other families, the disease starts earlier in subsequent members; this could be 
explained by a progressive decay of the gametal ergon of the affected gene. In two families, 
we observed a gradual chronon reduction not only within a generation but also from one 
generation to the other (Figs. 3 and 4). 
Unfortunately, there are few cases were both age of onset and age of death are reported. 
Therefore, nothing precise can be said on the length of the disease. 
Renal transplants can halt the disease. This was observed by Philippart et al. (1972) and 
by Desnick et al. (1972). The suggested chronogenetical explanation is that the transplanted 
kidney is able to compensate the genes deficiency, when these exhaust their informational 
capacity. 
AGE OF DEATH 
Fig. 5 shows the age of death of 39 patients affected by Fabry's disease. Age ranges from 
26 to 67 years. 
In one family, 4 brothers died at about the same age (Fig. 6). In three families, death struck 
earlier in the second generation, in particular: 
— 54 and 39 years of age (1/1 and HI/1) for family H of Wise (1960); 
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S1120962300023969
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 11 Jul 2017 at 15:51:59, subject to the Cambridge Core terms of use, available at
296 ALBERT TH. FRANCESCHETTI 
1 £ 
t9 
5t1 
0 
1993-
1949 
s- ^ ~~s~ — rTTi 
I 1990- I 199" 
1953 194 
IV 6'ft2 03 ft 05 M M " fi,2tf 4" I $'6 6 W 
...» 
_J3; 
V 
1915-45 11916- 1919-SI 
11964 27j 
' * 2 * ' * « * , S 
* • 
1947 
df 6' 69 S 4" 4" A13 
1946 1948 1949 1950 1951 1953 1954 
201 
>t14 + 1 5 +16 
1955 1957 1959 
12 r I I / 9 ) 
fi7 0" ar ft20 
1960 1961 1962 1963 
LJ = male O = female 
[ 1 3 = Cornea verticil lata 
died of nephrosclerosis 
or vascular disease 
(cornea not examined) 
0 0 = bio logically affected 
131 = Cornea verticillata, angiokeratoma 
corporis diffusum (Fabry) 
© = Carrier 
A = st i l l -b i r th 
x = Slitlamp examination 
20» = age of onset 
Genealogical free of cornea verMcillara(published by GRUBER.1946,family 2) 
| completed by A Th FRANCESCHETTI 1967 
Fig. 4 
$5 67 age at death 
Fig. 5. Age at death of 39 cases of Fabry's disease. 
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Fig. 6. Fabry's disease. [Family II of Christensen Lou 1967]. 
— 52 and 43 years of age (HI/6 and IV/15) for one of the families we observed in 1967 
(Fig. 4); 
— 54 and 32 (III/2 and IV/10) for family I of Christensen Lou et al. (1970, Fig. 2). 
This seems to hold true also for females, as III/3 died at 63 and IV/14 at 48 years in the 
family we observed (Fig. 4). 
In conclusion, chronogenetical analysis revealed interesting time relations in Fabry's 
disease. It is to be hoped that future studies on angiokeratoma corporis diffusum will pay 
due attention to chronogenetical factors. 
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